This collection covers GLP-1, GIP and related incretin and amylin peptide analogs, a family of long, modified peptides built around the biology of the gut hormones that regulate insulin secretion after a meal. Listings include single-receptor agonists, dual-receptor analogs and amylin-related compounds.
Native GLP-1 and GIP are broken down within minutes by the enzyme DPP-4, so most compounds in this collection are chemically modified, through amino acid substitutions or attached fatty-acid chains, to resist that breakdown and remain active in an assay for longer. Our guide GLP and GIP Peptides Explained covers the incretin system, the difference between single and dual agonists, and why these molecules are engineered the way they are.
Because these are longer, modified sequences, identity and purity are harder to achieve consistently than with short peptides, which makes batch documentation especially important. Before ordering, read how to read a certificate of analysis and our explanation of how HPLC and mass spectrometry testing actually works, so you know what a strong COA should include for a molecule of this size.
Some molecules studied alongside this family are also approved medicines, manufactured to pharmaceutical standards and prescribed by clinicians for specific conditions. The research-grade material listed here is a different category of product: it is sold for laboratory investigation only, is not interchangeable with any medicine, and is not accompanied by dosing or human-use instructions. If you are looking for shorter, single peptides instead, see the general Peptides collection.
New to this category? Read GLP and GIP Peptides Explained for the background before you order.
Read the guideGLP and GIP Peptides
Best Sellers
GLP and GIP Peptides
GLP and GIP Peptides
Best Sellers
GLP and GIP Peptides
GLP and GIP Peptides
GLP and GIP Peptides
GLP and GIP Peptides

